To determine the criterion validity of the FitBit® Flex™ compared to the ActiGraph's Bluetooth® Smart wGT3X-BT wireless activity monitor, and contribute to the clinical utility of accelerometry measurement of UE movement.
Full Title of Study: “Measuring Upper Extremity Functional Movement With Accelerometry: FitBit vs Actigraph”
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: May 1, 2016
Participants will wear two different accelerometers (FitBit and Actigraph) to record normal, everyday movement. Data from each accelerometer will be compared to determine similarity.
Arms, Groups and Cohorts
- Healthy adults
- Healthy adults without any limitations in upper extremity movement or function.
Clinical Trial Outcome Measures
- Time Frame: 24 hours
- Number of steps
Participating in This Clinical Trial
- Healthy adults with no upper extremity limitations
- Upper extremity limitations
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Rowe, Veronica, M.D.
- Provider of Information About this Clinical Study
- Principal Investigator: Veronica Rowe, Assistant Professor – Rowe, Veronica, M.D.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.